AIB Group PLC (A5G)
Irish Exchange · Ireland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 10.64 |
|---|---|
| 52-week range | 7.35 – 11.85 |
| Return, 1 month / 3 months | −8.4% / −0.2% |
| Return, 1 year / 3 years | +50.5% / +211.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 25.8% |
| Worst drawdown (1 year) | -13.1% |
| Average daily value traded | 49.92M EUR |
| Dividend yield | 6.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AIB Group is a bank based in Ireland that serves personal customers, small and medium businesses and larger corporate clients. It offers current and savings accounts, mortgages, personal loans, credit cards and overdrafts, alongside business lending, treasury services and payments. The group operates a branch network and digital banking services across Ireland and also runs operations in the United Kingdom, where it lends to business and personal customers.
The shares are listed on the Irish Exchange in Ireland under the code A5G, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AIB Group PLC (A5G) trades on the Irish Exchange in Ireland. It last closed at EUR 10.64 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 1 of 21 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 50.5% and over the last three months it fell 0.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Irish Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.0% | ||
| From 52-week high | -9.1% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.2% | ||
| 6-month return | 12.4% | ||
| 12-month return, skipping the last month | 64.4% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.1% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 49.92M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 88 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | −8.4% |
| 3 months | −0.2% |
| 6 months | +12.4% |
| 1 year | +50.5% |
| 3 years | +211.6% |
| 5 years | +479.3% |
Signals
| 50-day / 200-day average | 11.18 / 9.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | EUR 0.1953 |
| 26 Mar 2026 | EUR 0.4626 |
| 21 Aug 2025 | EUR 0.1233 |
| 27 Mar 2025 | EUR 0.3698 |
| 21 Mar 2024 | EUR 0.2657 |
| 30 Mar 2023 | EUR 0.0620 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Irish Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.